Moving towards risk-based surveillance and early detection of hepatocellular carcinoma

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Apr 20 / Springer Healthcare

Moving towards risk-based surveillance and early detection of hepatocellular carcinoma

Oncology Hepatocellular Carcinoma EASL-LIVER-CANCER-SUMMIT-2023

Description

Amit Singal and Peter Jepsen review the latest developments in risk-based surveillance and the early detection of hepatocellular carcinoma in light of the recent EASL policy statement for patients with cirrhosis.

Follow us here

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.